Table 3 Patient information
N = 84 | N | |
|---|---|---|
Median age | ||
(interquartile range) | 65 (53 – 70) | |
Gender | Male | 45 |
Female | 39 | |
Performance status | 0 – 1 | 61 |
≥ 2 | 23 | |
Histology | Adenocarcinoma | 50 |
Squamous Carcinoma | 15 | |
PDC/UDC | 15 | |
Malignant Neoplasm | 4 | |
Differentiation (grade) | 1 | 7 |
2 | 33 | |
3 | 44 | |
Clinicopathologic subgroup | Visceral | 29 |
Axillary nodal | 9 | |
Peritoneal carcinomatosis | 18 (15/3) | |
(Serous/Mucinous) | ||
Midline nodal | 10 | |
Squamous cervical nodal | 18 | |
Chemotherapy | Chemo (Yes / No) | 63/ 21 |
Platinum-based | 27 | |
Platinum + Taxane | 23 | |
Taxane-based | 3 | |
Other | 10 | |
Median PFS (95% CI) | 7 months (4.8 – 9.2) | |
Median OS (95% CI) | 12 months (8.7 – 15.3) |